The Movement Disorder Society Nonmotor Rating Scale: Initial Validation Study-Reference-Cited by-同舟云学术

The Movement Disorder Society Nonmotor Rating Scale: Initial Validation Study

Published:2019-09-30 Issue:1 Volume:35 Page:116-133
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord

Author:

Chaudhuri K. Ray¹^ORCID,Schrag Anette²^ORCID,Weintraub Daniel³⁴,Rizos Alexandra¹,Rodriguez‐Blazquez Carmen⁵,Mamikonyan Eugenia³,Martinez‐Martin Pablo⁵

Affiliation:

1. King's College London, Department of Neurosciences Institute of Psychiatry, Psychology & Neuroscience and Parkinson Foundation Centre of Excellence, King's College Hospital Denmark Hill London UK

2. Department of Clinical and Movement Neurosciences UCL Queen Square Institute of Neurology London UK

3. Department of Psychiatry and Neurology Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania USA

4. Parkinson's Disease Research Education and Clinical Center (PADRECC), Corporal Michael J. Crescenz Veterans Affairs Medical Center Philadelphia Pennsylvania USA

5. National Center of Epidemiology and CIBERNED, Carlos III Institute of Health Madrid Spain

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.27862

Reference38 articles.

1. Non-motor features of Parkinson disease

2. Non‐motor Parkinson disease: new concepts and personalised management

3. Comprehensive grading of Parkinson’s disease using motor and non-motor assessments: addressing a key unmet need

4. EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease

5. Levodopa–carbidopa intestinal gel in a subgroup of patients with dyskinesia at baseline from the GLORIA Registry

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune landscape of the enteric nervous system differentiates Parkinson's disease patients from controls: The PADUA-CESNE cohort;Neurobiology of Disease;2024-10

2. Non-motor symptoms in PD evaluated during pharmacological ON state by a new tool: The NoMoS-ON scale. Is always the "ON" state beneficial?;Parkinsonism & Related Disorders;2024-08

3. Molecular characterization of the circadian clock in patients with Parkinson’s disease–CLOCK4PD Study protocol;PLOS ONE;2024-07-19

4. Imbalance and Falls in Patients with Parkinson’s Disease: Causes and Recent Developments in Training and Sensor-Based Assessment;Brain Sciences;2024-06-22

5. Nonmotor Symptoms and Impulse Control Disorders in Parkinson’s Disease Patients in India: A Cross-sectional Study;Annals of African Medicine;2024-06-08